In this trial, apart from the increase in CD4+ and CD8+ T cell proliferation after vaccination, a comparison of tumor specimens before and after treatment revealed an increase in activated, conventional CD4+ TIL in most patients and higher clonality by TCRβ sequencing [57]. The gene discussed is CD8A; the disease is neoplasm.